A rterial stiffening is associated with development of hypertension, a risk factor for renal disease, heart failure, coronary artery disease, and stroke, particularly among the elderly. [1] [2] [3] [4] [5] [6] With aging, arterial stiffening leads to increased pulse wave velocity and pulse pressure, thereby predisposing individuals to hypertension, increased left ventricular afterload, and impaired coronary perfusion.
Results

Participant Characteristics at Examination 1
At examination 1, men and women were similar in regard to age and race/ethnicity (Table 1) . At examination 1, 441 (31.2%) women were current users of hormone replacement therapy with a duration of 9.9 (8.4) years. At examination 5, only 107 (7.6%) were hormone replacement therapy users. Overall, baseline distensibility coefficient (DC) did not differ significantly by sex, but expected sex-related differences were seen in artery sizes, thicknesses, and in certain CVD risk factors. YEM was higher in men, indicating stiffer arteries; men also had thicker carotid walls and artery sizes. As in a previous report from our group, men and women had similar rates of changes in DC and YEM (Table 1) . 8 At examination 1, black men and women had the lowest baseline DC (indicating more stiff arteries), whereas Chinese men and women had the highest baseline YEM (also indicating more stiff arteries). White men and women had the best distensibility measures. Black men and women had significantly higher mean systolic and diastolic blood pressure, body mass index, proportions with hypertension and using antihypertensive treatment, and carotid wall thickness (Supplement IV and Table IVA and IVB in the online-only Data Supplement).
Sex Differences in Predictors of Changes in DC and Young's Elastic Modulus
In models adjusted for baseline stiffness, men and women had different predictors of the rate of change in distensibility markers (Tables 2 and 3 Models were adjusted for baseline distensibility coefficient, age, ethnicity, education, diabetes mellitus, smoking, total and high-density lipoprotein cholesterol, body mass index, systolic blood pressure, antihypertensive treatment, and menopausal status (in models restricted to women). Model 2 used same covariates as model 1 except replaced baseline use of antihypertensive medication in model 1 with 4 categories: starting, stopping or continuing antihypertensive medications (compared with not taking antihypertensive medications throughout the observational period). Only those coefficients and SDs are provided because the others were similar.
*Variables with significance at P<0.10 in a parsimonious backward regression model.
(β=−400.6; P<0.01), indicating a protective effect in regard to arterial stiffening over time (Tables 2 and 3 ). Baseline use of lipid-lowering medications also was associated with decreasing YEM (β=−209.3; P=0.03). As with DC in men, higher systolic blood pressure at examination 1 was associated with increasing stiffness (DC, β=−0.003; P=0.02 and YEM, β=3.6; P=0.04). The use of antihypertensive therapy at baseline also was associated with increasing YEM in women (β=195.4; Tables 2 and 3 were rerun after excluding education, no major changes were observed. When formally tested for interactions with sex, the following variables demonstrated differences between the sexes. For DC, age (P=0.003) and total cholesterol (P=0.04). For YEM, education category (P=0.05) and use of lipid-lowering medication (P=0.05).
P=0.01). When the models in
At baseline, a higher percentage of women compared with men were hypertensive (42.6% and 39.8%, respectively, 
Trends in DC and YEM by Sex and Decade
Among those aged 45 to 54 years at baseline, women had significantly higher (less stiff) DC (P=0.003) than men. Beyond 55 years of age, DC was similar among the sexes (Table 4) . Similarly, women in the youngest age category (45-54 years) had a lower YEM than men of similar age. However, in the oldest age group (aged 75-84 years), women had a significantly higher YEM compared with men. Comparisons by decade showed no significant differences in baseline DC and YEM by sex between ages 55 to 64 and 65 to 74 years. Further analyses by decade revealed that men and women had similar rates of change of YEM, although not DC in the youngest age decade ( Table 5 ). The greatest changes in age-related stiffening for both men and women occurred in the oldest decades (aged 75-84 years) for DC and YEM. These findings are consistent with our prior analysis of carotid distensibility changes in MESA.
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Discussion
Despite similar rates of change in DC and YEM between men and women, this analysis highlights different predictors of change in carotid arterial stiffness parameters between the sexes for nearly a decade of follow-up. Sex-specific analyses revealed consistent results. In men, Chinese and black race/ ethnicity compared with white ethnicity and baseline systolic blood pressure were associated with more rapid stiffening (decreasing DC), whereas starting antihypertensive medication was associated with improved DC. Stopping antihypertensive medications was associated with increased stiffening (higher YEM). In women, higher education level was associated with slower rates of stiffening. Baseline use of lipid-lowering medication also predicted slower stiffening; however, baseline use of antihypertensive therapy and higher systolic blood pressure also predicted increasing YEM in women. Despite age-related differences in stiffness between men and women, these observations seem to be unrelated to menopausal status. A previous report from MESA found that the rate of change in distensibility markers did not differ significantly by ethnicity. 8 However, our data showed that stratified by sex, Chinese and black race/ethnicity were strongly associated with worsening DC in men. Our findings of YEM progression in men are consistent with results from The Northern Manhattan Study, which found greater arterial stiffening with older age among Hispanics compared with blacks or whites. 9 Sex-stratified models were also consistent with higher baseline (cross-sectional) stiffness in Hispanics and blacks compared with whites in that study. Our previous report from MESA described longitudinal improvements in DC among participants who started antihypertensive therapy. 8 This subsequent analysis only identified strong effects of starting or stopping antihypertensive medications on the progression rates of distensibility markers in men. This may be because of metabolic differences between men and women, [10] [11] [12] [13] because differing effects of antihypertensive therapy in women, and because women start antihypertensive therapy with more advanced arterial stiffness, so the effects of antihypertensive therapy may be blunted 14, 15 or may reflect delays to the diagnosis and undertreatment of hypertension in women. 16, 17 In women, baseline carotid stiffness measures were significantly worse after the age of 75 years, suggesting that older women bear a greater cardiac afterload than men and may be more predisposed to heart failure. 7 Sex-related differences in the effects of antihypertensive therapy on distensibility progression may reflect lower control rates in older hypertensive women than men despite greater awareness and higher treatment rates among women. 18, 19 Although some studies reported nonsignificant differences in control rates by sex, 20 our data show that among treated hypertensives at baseline, men had better hypertension control. Similar findings were observed among treated hypertensives at examination 5; however, the sex differences were not statistically significant. Age-related increases in CVD morbidity and mortality may reflect hormonal changes after the menopausal transition leading to a higher incidence of systolic hypertension and rapid arterial stiffening in women, although we were not able to identify an effect of menopause in our analyses. 21, 22 Sex differences in Table 4. †P<0.05 compared with each other decade within each sex.
preventive treatments also have been described among older women with history of myocardial infarction, who were less likely to receive lipid-lowering medication after an event and were less frequently treated with aspirin, β-blockers, or thrombolytic therapy during an acute event coronary syndrome. 23, 24 Given these imbalances, our data suggest that healthcare providers should address hypertension promptly and aggressively to help women optimize blood pressure control before arterial stiffness is evident or too far advanced, especially among women of low educational status. Early and effective blood pressure management may help limit progressive increases in YEM in women. Additional studies are needed to determine the degree to which hormonal imbalances and estrogen receptor activity contribute to arterial aging, and how the interaction of antihypertensive treatment with hormone replacement therapies affects distensibility progression.
Another important observation was that higher education status among women was strongly associated with slowing the progression of YEM and limiting the decline of DC. CVD risk factors are related inversely to educational status, a reliable marker of socioeconomic status that is closely associated with CVD risk factors. 25, 26 Previous studies also have found that over time, the gap in educational inequalities widened for women but persisted or narrowed for men, suggesting increased susceptibility to CVD for the lowest educated women. 27 Socioeconomic determinants including education and income likely contributed to CVD risk factor profiles. Educational status among women favored whites and blacks, particularly beyond high school. Hispanic and Chinese women were most disadvantaged in terms of education and income, and both groups had the highest (worst) baseline YEM.
Men in the youngest age category demonstrated stiffer vessels at baseline with a more rapid progression during the observation time period. Accelerated stiffening in younger men suggests earlier concentric remodeling, which may occur to accommodate blood pressure and larger arterial diameter. Adverse arterial remodeling is assessed by YEM, which takes into account wall thickness. Women in the oldest age category had the stiffest vessels at baseline but experienced a similar rate in progression as men for the decade. The advanced stiffness in the oldest women at baseline may reflect higher prevalence of systolic hypertension 21, 28 or impaired remodeling because of genetic or hormonal differences. Although we did not observe a significant association between menopause and stiffness progression in women, other studies have found that for postmenopausal women, the loss of estrogenic activity in arterial walls contributes to decreased elasticity and rapid stiffening. 21 The rate of decline in DC was most dramatic for both sexes between ages 75 to 84 years and was significant compared with each other decade within each sex. Among those aged >75 years, the rate of change in DC and YEM may have been blunted by floor and ceiling effects, meaning that there was minimal physiological capacity to stiffen more among the oldest participants with the most advanced degree of stiffening.
Limitations
As previously reported, 8 there was no significant interaction between sex and changes in DC or YEM, so the data in this report are subset analyses that attempt to describe and understand the differences in predictors of changes in carotid arterial stiffness measures among the sexes. When considering the sexes separately, our power to identify formal interactions was limited, although formal interaction testing did identify consistent differences for the effects of age, total cholesterol level, education category, and use of lipid-lowering medications that were consistent with our separate models for each sex. This report still is the largest assessment of sex-specific effects on progressive arterial stiffening to date. As an observational study, albeit a longitudinal one, this study is subject to certain biases and the possibility of residual confounding. For example, the findings related to educational status and stiffness in women may be explained by a factor correlated with it, such as nutritional quality, access to healthcare, air quality, or unmeasured factors. Also, these data are from a subset of MESA participants with valid distensibility measurements at baseline and examination 5. Those who survived to or who participated in examination 5 are healthier than those who did not, although this would be expected to create a null bias and limit identification of significant but weaker associations with the outcome measures. Because we only had stiffness measures at examinations 1 and 5, intermediate changes, the shape of the arterial stiffness progression curve, and our ability to discern cause and effect are limited. In this report, we used brachial artery blood pressures. Carotid artery blood pressures may vary because of pulse pressure amplification, which likely changed with aging and differs by height and sex; however, measurement of carotid blood pressures or waveforms in a large cohort was not feasible at the inception of this study. 2, 22 This technique used in this report has been adequate to find expected associations with risk factors for DC and YEM and aortic calcification in MESA in multiple previous publications. 7, 8, 29, 30 Finally, as a longitudinal observational study, we cannot exclude the possibility that some of our findings may be affected by unconsidered confounding. For example, the effect of educational status on longitudinal changes in DC and YEM likely is mediated by a physiological factor not captured in our models. To investigate this, we reran the full models in Tables 2 and 3 after excluding educational status; however, no major changes were detected.
Conclusions
Changes in carotid artery stiffness parameters more than a decade are associated with blood pressure and antihypertensive therapy in both men and women. However, in men, race/ ethnicity, and in women, educational level, may have differential contributions. These observations have implications for the pathophysiology and clinical management of age-related arterial stiffening. There is acceleration in arterial stiffening after the age of 75 years for both men and women.
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